CSL Seqirus, a business of CSL (ASX: CSL), announced recent data showing that cell-based influenza vaccines offer greater protection in preventing test-confirmed influenza compared to standard ...

CSL Seqirus real-world study finds cell-based flu vaccines offer stronger protection than egg-based options in 2023/24 season ...

Viruses have no metabolism of their own and must therefore infect host cells in order to replicate. Contact between the virus and the cell surface is a crucial first step, which can also prevent ...

Late in the Middle Ages, Italian stargazers gave a name to the annual contagion that rolled around each year like clockwork.

CSL Seqirus, the vaccine unit of Australian biotech CSL, has signed a pact to provide Saudi Arabia with cell-based influenza shots and help establish its production in-country. The move forms part of ...

The influenza virus manipulates the body’s gene regulation system to accelerate its own spread, according to researchers at the University of Gothenburg. Their study also shows that an already ...

Australia's CSL said on Thursday its vaccine arm, CSL Seqirus and Vaccine Industrial Company, had inked a deal with Saudi Arabia's Health Ministry to localize manufacturing of cell-based seasonal and ...

New findings published in the journal Nature, led by a clinical microbiologist, Kelvin To, at the University of Hong Kong, ...

A bird flu virus that has often been ignored because it mostly causes minor disease in birds has the potential to cause a ...

December 12, 2011 — Children with sickle cell anemia who receive the trivalent inactivated influenza vaccine are no more likely to be hospitalized for sickle cell crisis than children with sickle cell ...